advertisement
Men's Health News
June 29, 2023

Top Headlines

A New Combination Therapy Regimen Shows Promising Results for Prostate Cancer

The combination of two oral medications has shown positive results in people with prostate cancer, whose disease has spread to other parts of the body. Compared with XTANDI plus placebo, the investigatory combination of TALZENNA and XTANDI ...

Mediterranean Diet the Best Prevention Against Prostate Cancer

New research shows that men who stick to a predominantly Mediterranean diet are less likely to be diagnosed with prostate cancer. This diet also improves their chances of recovery if they have PC and are undergoing radiation ...

The New Prostate Cancer Blood Test With 94 Per Cent Accuracy

Researchers have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods. New research shows that the Prostate Screening EpiSwitch (PSE) blood test is 94 per cent accurate -- beating the currently used prostate-specific antigen (PSA) blood test. The ...

Developing Therapies for Treatment-Resistant Prostate Cancer

In a recent trial, nine patients whose tumors were resistant to androgen-blocking therapy continued that therapy but were also given a CD105 inhibitor called carotuximab. Forty percent of those patients experienced progression-free survival, based on radiographic ...
advertisement

Latest Headlines
updated 4:30pm EDT

Earlier Headlines

New Epigenetic Markers for Prostate Cancer Discovered

New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been ...

Researchers Identify Drug Resistance Factors for Advanced Prostate Cancer

Researchers have identified critical genomic changes in response to abiraterone acetate/prednisone, a standard treatment option for men with progressive, incurable and castration-resistant prostate ...

Aggressive Prostate Cancer Linked to Ancestral Heritage

Two pioneering studies have identified genetic signatures explaining ethnic differences in the severity of prostate cancer, particularly in sub-Saharan ...

Considering Genetic Risk in Prostate Cancer Referrals Could Lead to Earlier Diagnosis

A large-scale study looked at the impact of incorporating genetic risk for cancer into the GP triage and referral processes in the UK. The research concluded that considering genetic risk could ...

Prostate Cancer Cases Risk Being Detected Too Late Due to Misleading Focus on Urinary Problems

Men with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines and media health campaigns focus on urinary symptoms despite a ...

Prognosis of Prostate Cancer Patients Improved

前列腺cancer is a common form of cancer. Researchers have now discovered a faster and easier way to determine who has an aggressive form of cancer, and who has ...

Mechanism Leading to Drug Resistance in Prostate Cancer

Researchers reveal a mechanism by which prostate cancer cells become resistant through molecular modification of the androgen receptor protein and identify a potential treatment approach that could ...

High-Intensity Focused Ultrasound (HIFU) Can Control Prostate Cancer With Fewer Side Effects

High-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or ...

Hormones Contribute to Sex Disparities in Bladder Cancer, Study Shows

Male sex hormones interfere with the body's ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new ...

New Cancer Subtype May Illuminate Treatment Strategy

Researchers have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth. This discovery opens the door to the ...

New Combined Therapy Helps Extend Lives of Men With Prostate Cancer

Practice-changing research shows that a combination of androgen deprivation therapy -- a commonly used hormone injection -- plus pelvic lymph node radiation, kept nearly 90% of clinical trial ...

advertisement

How Tumor Cells Use Mitochondria to Keep Growing

Investigators have discovered that tumor cells use mitochondria to control their growth and detect stress that can destroy a tumor cell if it is not ...

Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men ...

小说在Oncogenesi治疗药物可能会减少s of Metastatic Prostate Cancer

Researchers have found that treating prostate cancer cells with novel cyclin-dependent kinase 19 (CDK19) and homologous cyclin-dependent kinase 8 (CDK8) inhibitors reduces their potential to migrate ...

Researchers Look to Licorice for Promising Cancer Treatments

A research review into molecular insights of a licorice-derived substance called glycyrrhizin for preventing or treating cancer suggests further research could lead to specific agents for clinical ...

Cause of Metastasis in Prostate Cancer Discovered

前列腺cancers remain localized in the majority of cases, giving affected individuals a good chance of survival. However, about 20% of patients develop incurable metastatic prostate cancer, ...

Metastatic Prostate Cancer on the Rise Since Decrease in Cancer Screenings

A new study finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against routine prostate cancer ...

New Risk Algorithm Would Improve Screening for Prostate Cancer

Researchers developed an algorithm estimating a person's risk of developing prostate cancer based on age and the levels of two prostate cancer markers, PSA and hK2 (human kalliknein peptidase). ...

Ultrasound Scan Can Diagnose Prostate Cancer

An ultrasound scan can be used to detect cases of prostate cancer, according to new ...

Three-Drug Combination Prolongs Survival in Men With Metastatic, Hormone-Sensitive Prostate Cancer

Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy ...

Monday, October 3, 2022
Thursday, September 22, 2022
Wednesday, August 31, 2022
Thursday, August 18, 2022
Wednesday, August 3, 2022
Monday, July 18, 2022
Wednesday, June 15, 2022
星期四,2022年6月9日
Friday, May 27, 2022
Thursday, May 26, 2022
Tuesday, May 10, 2022
Friday, April 22, 2022
Wednesday, April 13, 2022
Wednesday, April 6, 2022
Monday, April 4, 2022
Monday, March 14, 2022
Tuesday, March 8, 2022
Monday, February 28, 2022
Friday, February 18, 2022
Friday, January 28, 2022
Thursday, January 27, 2022
Tuesday, January 25, 2022
Thursday, January 13, 2022
Wednesday, January 12, 2022
Monday, November 29, 2021
Tuesday, November 16, 2021
Friday, November 5, 2021
Tuesday, November 2, 2021
Thursday, October 28, 2021
Tuesday, October 19, 2021
Thursday, October 7, 2021
Tuesday, October 5, 2021
Thursday, September 23, 2021
Thursday, September 16, 2021
Monday, August 23, 2021
Friday, August 13, 2021
Wednesday, July 7, 2021
Wednesday, May 19, 2021
Thursday, May 6, 2021
Monday, March 8, 2021
Wednesday, February 17, 2021
Thursday, February 11, 2021
Monday, February 1, 2021
Friday, January 15, 2021
Monday, January 11, 2021
Thursday, January 7, 2021
Monday, January 4, 2021
Monday, December 21, 2020
Tuesday, November 10, 2020
Wednesday, October 7, 2020
Tuesday, September 29, 2020
Thursday, September 3, 2020
advertisement